Open AccessClinical Practice Guidelines for Hepatic Arterial Infusion Chemotherapy with a Port System Proposed by the Japanese Society of Interventional Radiology and Japanese Society of Implantable Port Assisted Treatment
Author(s) -
Ueshima Kazuomi,
Komemushi Atsushi,
Aramaki Takeshi,
Iwamoto Hideki,
Obi Shuntaro,
Sato Yozo,
Tanaka Toshihiro,
Matsueda Kiyoshi,
Moriguchi Michihisa,
Saito Hiroya,
Sone Miyuki,
Yamagami Takuji,
Inaba Yoshitaka,
Kudo Masatoshi,
Arai Yasuaki
Publication year - 2022
Publication title -
liver cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.916
H-Index - 34
eISSN - 1664-5553
pISSN - 2235-1795
DOI - 10.1159/000524893
Subject(s) - guidelines
Hepatocellular carcinoma is one of the leading causes of cancer-related death both in Japan and globally. In the advanced stage, hepatic arterial infusion chemotherapy (HAIC) is one of the most commonly used treatment options for liver cancer in Japan, and implantation of a catheter system (called a port system) in the body is a treatment method that has evolved mainly in Japan. The Guideline Committee of the Japanese Society of Interventional Radiology and the Japanese Society of Implantable Port Assisted Treatment jointly published clinical practice guidelines for HAIC with a port system to ensure its appropriate and safe performance in Japanese in 2018. We have written an updated English version of the guidelines with the aim of making this treatment widely known to experts globally. In this article, the evidence, method, indication, treatment regimen, and maintenance of the system are summarized.